SECOND OPINION: PFIZER’S PHONY CALL FOR LOWER DRUG COSTS
Jun 22, 2021
CEO Sidesteps Big Pharma’s Pricing Practices; Pushes Proposals That Would… Read More
© 2025 CSRXP- All Rights Reserved
Updates
CSRXP: WYDEN RX PRICING PRINCIPLES ADD TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE
Jun 22, 2021
Lawmakers Must Advance Solutions to Lower Drug Prices Washington,… Read More
WHAT THEY ARE SAYING: BIOGEN’S “SIMPLY UNACCEPTABLE” ADUCANUMAB PRICING HIGHLIGHTS URGENCY FOR RX SOLUTIONS
Jun 14, 2021
Broad-based Opposition to Egregious Launch Price on Drug With Unproven… Read More
CSRXP: FDA APPROVAL AND SUBSEQUENT BIOGEN PRICING OF ADUCANUMAB DEMAND RETROSPECTION, REFORM
Jun 11, 2021
Troubling for Public Health Institution to Depart from Established Norms to… Read More
ICYMI: BIG PHARMA’S FASTER-THAN-INFLATION PRICE HIKES COSTING MEDICARE BILLIONS OF DOLLARS
Jun 7, 2021
AARP Study Finds Brand Name Drug Companies Increased Prices Above Rate of… Read More
SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
Jun 7, 2021
For far too long Big Pharma has used the excuse that research and development… Read More
CSRXP AD BLITZ: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE NOW
Jun 1, 2021
Campaign Calls for Promises Made to the American People to Lower Prescription… Read More
CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET
May 28, 2021
Time for the Administration and Congress to Convert Promises Made Into… Read More
THEY SAID IT! ABBVIE CEO BRAGS ON ABILITY TO HIKE PRICES IN U.S., ADMITS COMPETITION WORKS AND CONFIRMS BIG PHARMA PATENT GAMES DESIGNED FOR “PRICING POWER”
May 19, 2021
House Oversight Lawmakers Commit to Bipartisan Action to Hold Big Pharma… Read More
DOSE OF REALITY: HUMIRA: A CASE STUDY IN BIG PHARMA GREED
May 17, 2021
AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive… Read More
THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS
May 5, 2021
Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE & ASTRAZENECA
May 5, 2021
Drug Companies Top Wall Street Expectations; Pfizer Raises Guidance Based On… Read More